| 1 | Daclizumab (Zenapax) | 1件:  Daclizumab Daclizumab | 1件:  Daclizumab 
                
                    Daclizumab
                
             (Zenapax) 💬
 | 1件:  IL2RA IL2RA 💬
 | 11件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件:  13 13, 56, 60, 65, 97, 107, 283, 284 💬
 | 
| 2 | Daclizumab high yield process (Zenapax) | 1件:  Daclizumab Daclizumab | 1件:  Daclizumab 
                
                    Daclizumab
                
             (Zenapax) 💬
 | 1件:  IL2RA IL2RA 💬
 | 11件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件:  13 13 💬
 | 
| 3 | Daclizumab HYP (Zenapax) | 1件:  Daclizumab Daclizumab | 1件:  Daclizumab 
                
                    Daclizumab
                
             (Zenapax) 💬
 | 1件:  IL2RA IL2RA 💬
 | 11件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件:  13 13 💬
 | 
| 4 | Daclizumab HYP (DAC HYP (Zenapax) | 1件:  Daclizumab Daclizumab | 1件:  Daclizumab 
                
                    Daclizumab
                
             (Zenapax) 💬
 | 1件:  IL2RA IL2RA 💬
 | 11件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件:  13 13 💬
 | 
| 5 | Daclizumab HYP (DAC HYP) (Zenapax) | 1件:  Daclizumab Daclizumab | 1件:  Daclizumab 
                
                    Daclizumab
                
             (Zenapax) 💬
 | 1件:  IL2RA IL2RA 💬
 | 11件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件:  13 13 💬
 | 
| 6 | Daclizumab with greek suufix (Zenapax) | 1件:  Daclizumab Daclizumab | 1件:  Daclizumab 
                
                    Daclizumab
                
             (Zenapax) 💬
 | 1件:  IL2RA IL2RA 💬
 | 11件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件:  13 13 💬
 | 
| 7 | Zenapax | - | - | - | - | 1件:  13 13 💬
 |